KALA BIO, Inc. - stock earnings
KALA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -8.7 million USD | ? USD |
| 2023Q2 | -10.4 million USD | ? USD |
| 2023Q1 | -18.7 million USD | ? USD |
| 2022Q4 | -13.9 million USD | 1.2 million USD |
| 2022Q3 | 73.4 million USD | 420000 USD |
| 2022Q2 | -27.3 million USD | 2.1 million USD |
| 2022Q1 | -33.0 million USD | 1.4 million USD |
| 2021Q4 | -47.6 million USD | 1.9 million USD |
| 2021Q3 | -28.1 million USD | 3.1 million USD |
| 2021Q2 | -36.5 million USD | 3.1 million USD |
| 2021Q1 | -30.4 million USD | 3.3 million USD |
| 2020Q4 | -31.1 million USD | 2.2 million USD |
| 2020Q3 | -27.9 million USD | 2.2 million USD |
| 2020Q2 | -23.3 million USD | 833000 USD |
| 2020Q1 | -22.0 million USD | 1.1 million USD |
| 2019Q4 | -22.0 million USD | 1.2 million USD |
| 2019Q3 | -23.2 million USD | 1.5 million USD |
| 2019Q2 | -23.8 million USD | 2.1 million USD |
| 2019Q1 | -25.4 million USD | 1.4 million USD |
| 2018Q4 | -25.2 million USD | ? USD |
| 2018Q3 | -15.6 million USD | ? USD |
| 2018Q2 | -14.6 million USD | ? USD |
| 2018Q1 | -11.3 million USD | ? USD |
| 2017Q4 | -11.3 million USD | ? USD |
| 2017Q3 | -10.2 million USD | ? USD |
| 2017Q2 | -11.0 million USD | ? USD |
| 2017Q1 | -9.8 million USD | ? USD |
| 2016Q4 | -8.4 million USD | ? USD |
| 2016Q3 | -9.7 million USD | ? USD |
| 2016Q2 | -9.9 million USD | ? USD |
| 2016Q1 | -5.3 million USD | ? USD |
| 2015Q4 | -16.7 million USD | 45000 USD |
KALA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -46.4 million USD | ? USD |
| 2022 | -223000 USD | 3.9 million USD |
| 2021 | -152.3 million USD | 11.2 million USD |
| 2020 | -112.0 million USD | 6.4 million USD |
| 2019 | -102.0 million USD | 6.1 million USD |
| 2018 | -66.7 million USD | ? USD |
| 2017 | -42.2 million USD | ? USD |
| 2016 | -33.2 million USD | ? USD |
| 2015 | -16.7 million USD | 45000 USD |
| 2014 | -19.4 million USD | 455000 USD |
KALA
Price: $7.01
52 week price:
Earnings Per Share: -17.35 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 20.3 million